TrialScientific reports2017

Fatigue-related impairments in oculomotor control are prevented by norepinephrine-dopamine reuptake inhibition.

Charlotte J W Connell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.